Abbott Laboratories total revenue, net income and dynamics of changes in US dollar today
Abbott Laboratories current income and income for the latest reporting periods. Net income Abbott Laboratories - 1 189 000 000 $. Information about net income is used from open sources. Net income, revenue and dynamics - the main financial indicators of Abbott Laboratories. The financial report schedule from 30/06/2017 to 30/06/2021 is available online. The financial report on the chart of Abbott Laboratories allows you to clearly see the dynamics of fixed assets. A graph of the value of all Abbott Laboratories assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
10 223 000 000 $
+28.12 % ↑
1 189 000 000 $
+18.19 % ↑
31/03/2021
10 456 000 000 $
+38.77 % ↑
1 793 000 000 $
+166.82 % ↑
31/12/2020
10 701 000 000 $
+28.71 % ↑
2 162 000 000 $
+106.1 % ↑
30/09/2020
8 853 000 000 $
+9.62 % ↑
1 232 000 000 $
+28.33 % ↑
31/12/2019
8 314 000 000 $
-
1 049 000 000 $
-
30/09/2019
8 076 000 000 $
-
960 000 000 $
-
30/06/2019
7 979 000 000 $
-
1 006 000 000 $
-
31/03/2019
7 535 000 000 $
-
672 000 000 $
-
31/12/2018
7 765 000 000 $
-
654 000 000 $
-
30/09/2018
7 656 000 000 $
-
563 000 000 $
-
30/06/2018
7 767 000 000 $
-
733 000 000 $
-
31/03/2018
7 390 000 000 $
-
418 000 000 $
-
31/12/2017
7 589 000 000 $
-
-828 000 000 $
-
30/09/2017
6 829 000 000 $
-
603 000 000 $
-
30/06/2017
6 637 000 000 $
-
283 000 000 $
-
Show:
to
Abbott Laboratories financial report charts
The latest dates of Abbott Laboratories financial statements available online: 30/06/2017, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Abbott Laboratories is 30/06/2021. Gross profit Abbott Laboratories is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Abbott Laboratories is 5 807 000 000 $
Abbott Laboratories quarterly report dates
Cost of revenue Abbott Laboratories is the total cost of producing and distributing of products and services of a company. Cost of revenue Abbott Laboratories is 4 416 000 000 $ Total revenue Abbott Laboratories refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Abbott Laboratories is 10 223 000 000 $ Operating income Abbott Laboratories is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Abbott Laboratories is 1 941 000 000 $
Net income Abbott Laboratories is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Abbott Laboratories is 1 189 000 000 $
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
5 807 000 000 $
6 056 000 000 $
6 207 000 000 $
4 887 000 000 $
4 942 000 000 $
4 718 000 000 $
4 700 000 000 $
4 391 000 000 $
4 574 000 000 $
4 490 000 000 $
4 485 000 000 $
4 323 000 000 $
4 326 000 000 $
3 972 000 000 $
3 464 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
4 416 000 000 $
4 400 000 000 $
4 494 000 000 $
3 966 000 000 $
3 372 000 000 $
3 358 000 000 $
3 279 000 000 $
3 144 000 000 $
3 191 000 000 $
3 166 000 000 $
3 282 000 000 $
3 067 000 000 $
3 263 000 000 $
2 857 000 000 $
3 173 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
10 223 000 000 $
10 456 000 000 $
10 701 000 000 $
8 853 000 000 $
8 314 000 000 $
8 076 000 000 $
7 979 000 000 $
7 535 000 000 $
7 765 000 000 $
7 656 000 000 $
7 767 000 000 $
7 390 000 000 $
7 589 000 000 $
6 829 000 000 $
6 637 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
8 314 000 000 $
8 076 000 000 $
7 979 000 000 $
7 535 000 000 $
7 765 000 000 $
7 656 000 000 $
7 767 000 000 $
7 390 000 000 $
7 589 000 000 $
6 829 000 000 $
6 637 000 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 941 000 000 $
2 177 000 000 $
2 531 000 000 $
1 447 000 000 $
1 550 000 000 $
1 253 000 000 $
1 262 000 000 $
832 000 000 $
1 165 000 000 $
995 000 000 $
882 000 000 $
608 000 000 $
691 000 000 $
810 000 000 $
427 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 189 000 000 $
1 793 000 000 $
2 162 000 000 $
1 232 000 000 $
1 049 000 000 $
960 000 000 $
1 006 000 000 $
672 000 000 $
654 000 000 $
563 000 000 $
733 000 000 $
418 000 000 $
-828 000 000 $
603 000 000 $
283 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
652 000 000 $
654 000 000 $
643 000 000 $
580 000 000 $
558 000 000 $
596 000 000 $
577 000 000 $
670 000 000 $
562 000 000 $
574 000 000 $
575 000 000 $
589 000 000 $
613 000 000 $
562 000 000 $
513 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
8 282 000 000 $
8 279 000 000 $
8 170 000 000 $
7 406 000 000 $
6 764 000 000 $
6 823 000 000 $
6 717 000 000 $
6 703 000 000 $
3 409 000 000 $
3 495 000 000 $
3 603 000 000 $
3 715 000 000 $
3 635 000 000 $
3 162 000 000 $
3 037 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
-
21 817 000 000 $
20 441 000 000 $
17 390 000 000 $
-
16 119 000 000 $
15 195 000 000 $
14 409 000 000 $
-
-
-
14 964 000 000 $
20 147 000 000 $
21 377 000 000 $
19 983 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
-
72 785 000 000 $
72 548 000 000 $
69 043 000 000 $
-
68 539 000 000 $
68 427 000 000 $
67 610 000 000 $
-
-
-
70 908 000 000 $
76 250 000 000 $
72 248 000 000 $
71 151 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
-
8 054 000 000 $
6 838 000 000 $
4 480 000 000 $
-
4 091 000 000 $
3 137 000 000 $
3 022 000 000 $
-
-
-
3 857 000 000 $
9 407 000 000 $
11 012 000 000 $
9 675 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
-
10 491 000 000 $
9 062 000 000 $
9 113 000 000 $
-
-
-
737 000 000 $
714 000 000 $
715 000 000 $
221 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
-
4 042 000 000 $
9 610 000 000 $
11 199 000 000 $
9 835 000 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
-
36 520 000 000 $
36 533 000 000 $
36 481 000 000 $
-
-
-
21 891 000 000 $
27 924 000 000 $
24 025 000 000 $
24 031 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
-
53.28 %
53.39 %
53.96 %
-
-
-
30.87 %
36.62 %
33.25 %
33.77 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
33 562 000 000 $
33 562 000 000 $
32 784 000 000 $
31 386 000 000 $
31 817 000 000 $
31 817 000 000 $
31 686 000 000 $
30 925 000 000 $
-
-
-
31 399 000 000 $
30 897 000 000 $
32 032 000 000 $
31 602 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-
1 948 000 000 $
1 060 000 000 $
712 000 000 $
-
-
-
1 108 000 000 $
1 640 000 000 $
2 005 000 000 $
1 351 000 000 $
Last revenue report of Abbott Laboratories was 30/06/2021. According to last financial report total revenue in Abbott Laboratories was 10 223 000 000 US dollar and changed by +28.12% since last year. Net income in Abbott Laboratories was 1 189 000 000 $ in last quartal, net income changes to +18.19%.
